Furthermore, the clinicopathological significance and prognostic value of PLK1 in Middle Eastern CRC patients have yet to be investigated, suggesting the clinical demand to further investigate PLK1 dysregulation in CRC from different ethnicities and to investigate the potential mechanism of PLK1 inhibitors in CRC. The gene discussed is PLK1; the disease is colorectal carcinoma.